Magenta Therapeutics to Participate in Panel Discussion at the 2022 Wedbush PacGrow Healthcare Conference

Rhea-AI Summary

Magenta Therapeutics (Nasdaq: MGTA), a biotechnology company, announced its participation in the Gene Modulation Panel Discussion at the 2022 Wedbush PacGrow Healthcare Conference on August 9, 2022, at 9:45 a.m. ET. This virtual event aims to highlight the company's mission to expand the curative potential of stem cell transplants for patients with blood cancers, genetic, and autoimmune diseases. The panel will be accessible through a live webcast, with a replay available for 30 days. Magenta is located in Cambridge, Massachusetts, and focuses on innovative therapies in stem cell biology.

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplant to more patients, today announced that the company will participate in a Gene Modulation Panel Discussion at the 2022 Wedbush PacGrow Healthcare Conference, to be held virtually, on Tuesday, August 9^th, 2022 at 9:45 a.m. ET.

A live webcast of the panel can be accessed on the Magenta Therapeutics website at https://investor.magentatx.com/events-and-presentations. The webcast replay will be available for 30 days following the event.

About Magenta Therapeutics
Magenta Therapeutics is a clinical-stage biotechnology company developing medicines designed to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise to revolutionize immune and blood reset to allow more patients to take advantage of the curative potential of stem cell transplant as well as potentially improve eligibility for future gene therapies.

Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.

Contact:
Jill Bertotti, Real Chemistry (advisor to Magenta)
714-225-6726
jbertotti@realchemistry.com

FAQ

When will Magenta Therapeutics participate in the Wedbush PacGrow Healthcare Conference?

Magenta Therapeutics will participate in the conference on August 9, 2022, at 9:45 a.m. ET.

How can I watch the Gene Modulation Panel Discussion?

The Gene Modulation Panel Discussion can be accessed via a live webcast on Magenta Therapeutics' website.

How long will the webcast replay of the panel discussion be available?

The webcast replay will be available for 30 days following the event.

What is the focus of Magenta Therapeutics?

Magenta Therapeutics focuses on developing medicines aimed at leveraging the curative power of stem cell transplants for patients with blood cancers and other diseases.

What is the stock symbol for Magenta Therapeutics?

The stock symbol for Magenta Therapeutics is MGTA.